Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains
- PMID: 20692337
- DOI: 10.1016/j.bbadis.2010.07.022
Effect of lysine modification on the stability and cellular binding of human amyloidogenic light chains
Abstract
AL amyloidosis is characterized by the pathologic deposition as fibrils of monoclonal light chains (i.e., Bence Jones proteins [BJPs]) in particular organs and tissues. This phenomenon has been attributed to the presence in amyloidogenic proteins of particular amino acids that cause these molecules to become unstable, as well as post-translational modifications and, in regard to the latter, we have investigated the effect of biotinylation of lysyl residues on cell binding. We utilized an experimental system designed to test if BJPs obtained from patients with AL amyloidosis or, as a control, multiple myeloma (MM), bound human fibroblasts and renal epithelial cells. As documented by fluorescence microscopy and ELISA, the amyloidogenic BJPs, as compared with MM components, bound preferentially and this reactivity increased significantly after chemical modification of their lysyl residues with sulfo-NHS-biotin. Further, based on tryptophan fluorescence and circular dichroism data, it was apparent that their conformation was altered, which we hypothesize exposed a binding site not accessible on the native protein. The results of our studies indicate that post-translational structural modifications of pathologic light chains can enhance their capacity for cellular interaction and thus may contribute to the pathogenesis of AL amyloidosis and multiple myeloma.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.Biophys Chem. 2017 Nov;230:89-98. doi: 10.1016/j.bpc.2017.08.011. Epub 2017 Sep 1. Biophys Chem. 2017. PMID: 28916410 Free PMC article.
-
Structural analysis of the amyloidogenic kappa Bence Jones protein (FUR).Amyloid. 1999 Jun;6(2):77-88. doi: 10.3109/13506129909007307. Amyloid. 1999. PMID: 10439113
-
Nephrotoxic potential of Bence Jones proteins.N Engl J Med. 1991 Jun 27;324(26):1845-51. doi: 10.1056/NEJM199106273242603. N Engl J Med. 1991. PMID: 1904132
-
Tetramer Bence Jones protein in the immunoproliferative diseases. Angioimmunoblastic lymphadenopathy, primary amyloidosis, and multiple myeloma.Am J Clin Pathol. 1989 Jun;91(6):639-46. doi: 10.1093/ajcp/91.6.639. Am J Clin Pathol. 1989. PMID: 2499179 Review.
-
Proteinuria in multiple myeloma and related diseases.Am J Nephrol. 1990;10 Suppl 1:58-62. doi: 10.1159/000168195. Am J Nephrol. 1990. PMID: 2124083 Review.
Cited by
-
Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation.Chem Commun (Camb). 2016 Oct 15;52(76):11318-34. doi: 10.1039/c6cc04640a. Epub 2016 Aug 22. Chem Commun (Camb). 2016. PMID: 27546596 Free PMC article.
-
Current perspectives on cardiac amyloidosis.Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H544-52. doi: 10.1152/ajpheart.00815.2011. Epub 2011 Nov 4. Am J Physiol Heart Circ Physiol. 2012. PMID: 22058156 Free PMC article. Review.
-
Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.J Biol Chem. 2017 Feb 10;292(6):2328-2344. doi: 10.1074/jbc.M116.750323. Epub 2016 Dec 28. J Biol Chem. 2017. PMID: 28031465 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials